BEHAVIOUR OF INSULINAEMIA IN PATIENTS WITH LIVER CIRRHOSIS AFTER INTRAVENOUS ADMINISTRATION OF GLUCOSE, TOLBUTAMIDE AND GLUCAGON

被引:16
作者
KASPERSK.T
LAWECKI, J
ROGALA, H
CZYZYK, A
机构
关键词
D O I
10.1007/BF01219476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:391 / +
页数:1
相关论文
共 18 条
[1]  
BOLLER R., 1932, Klinische Wochenschrift, V11, P671, DOI 10.1007/BF01781401
[2]  
CERASI R, 1970, ACTA DIABETOL LAT S1, V7, P289
[3]  
Creutzfeldt W, 1970, Prog Liver Dis, V3, P371
[4]  
CREUTZFELDT W, 1959, Acta Hepatosplenol, V6, P156
[5]  
CREUTZFELDT W, 1967, ACTA DIABETOL LAT S1, V4, P209
[6]  
CREUTZFELDT W, 1970, ACTA DIABETOL LAT S1, V7, P341
[7]  
CZYZYK A, 1970, DIABETES MELLITUS, P133
[8]  
HELLMAN B, 1969, ENDOCRINOLOGY, V84, P1
[9]   EFFECTS OF HYPERGLYCEMIA, TOLBUTAMIDE AND GLUCAGON ON PATHWAYS OF GLUCOSE OXIDATION IN GOOSEFISH ISLET IN-VITRO [J].
HOSTETLE.KY ;
WILLIAMS, HR .
DIABETES, 1970, 19 (08) :554-&
[10]  
Lambert A E, 1970, Acta Diabetol Lat, V7 Suppl 1, P229